Last week’s hot topic on pulmonary hypertension was PAH Oral Prostacyclin Analog Drugs, Like Treprostinil, Are Improving But Have Way to Go, written by Magdalena Kegel.
This article is about how prostacyclin analogs drugs have substantially improved pulmonary arterial hypertension (PAH) treatment, but the use of these drugs is hampered by the difficulties and risks of treating patients with continuous intravenous infusions. A new overview highlighted the development of oral prostacyclins, focusing on the drug treprostinil (Orenitram).
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?